The 81st Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Morning Seminar

MS2-12 Importance of Iron Chelation Therapy in Lower-risk MDS and Scheme to Prevent Overlook

Sat. Oct 12, 2019 7:55 AM - 8:40 AM No.12 (Tokyo International Forum, 5F G510)

Chairs: Akihiko Gotoh（Department of Hematology, Tokyo Medical University）, Shin Fujisawa（Department of Hematology, Yokohama City University Medical Center）

Sponsor: Novartis Pharma K.K.

[MS2-12] Importance of Iron Chelation Therapy in Lower-risk MDS and Scheme to Prevent Overlook

Yasuyoshi Morita1, Eisaburo Sueoka2 (1.Division of Hematology and Rheumatology, Department of Internal Medicine, Faculty of Medicine Kindai University, 2.Department of Clinical Laboratory Medicine, Faculty of Medicine, Saga University)

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.Password is written on a program book.

Password